A detailed history of Bank Of America Corp transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 1,294,008 shares of MRVI stock, worth $9.05 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,294,008
Previous 540,306 139.5%
Holding current value
$9.05 Million
Previous $3.54 Million 217.01%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$5.11 - $8.76 $3.85 Million - $6.6 Million
753,702 Added 139.5%
1,294,008 $11.2 Million
Q4 2023

Feb 14, 2024

SELL
$4.7 - $9.87 $2.8 Million - $5.89 Million
-596,790 Reduced 52.48%
540,306 $3.54 Million
Q2 2023

Aug 14, 2023

BUY
$12.09 - $15.0 $8.1 Million - $10.1 Million
670,007 Added 143.44%
1,137,096 $14.1 Million
Q1 2023

May 12, 2023

BUY
$12.99 - $16.48 $3.73 Million - $4.74 Million
287,434 Added 159.99%
467,089 $6.54 Million
Q4 2022

Feb 10, 2023

BUY
$12.5 - $24.78 $951,575 - $1.89 Million
76,126 Added 73.53%
179,655 $2.57 Million
Q3 2022

Nov 14, 2022

SELL
$20.6 - $30.37 $2.26 Million - $3.34 Million
-109,902 Reduced 51.49%
103,529 $2.64 Million
Q2 2022

Aug 12, 2022

SELL
$26.05 - $37.48 $4.93 Million - $7.09 Million
-189,148 Reduced 46.98%
213,431 $6.06 Million
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $1.03 Million - $1.72 Million
-41,973 Reduced 9.44%
402,579 $14.2 Million
Q4 2021

Feb 08, 2022

SELL
$35.0 - $45.94 $890,925 - $1.17 Million
-25,455 Reduced 5.42%
444,552 $18.6 Million
Q3 2021

Nov 15, 2021

BUY
$36.8 - $60.62 $1.28 Million - $2.11 Million
34,792 Added 7.99%
470,007 $23.1 Million
Q2 2021

Sep 13, 2021

BUY
$32.46 - $45.0 $14.1 Million - $19.6 Million
435,215 New
435,215 $18.2 Million

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $919M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.